Example #1: The Board of each Fund has determined that the use of this Joint Proxy Statement for each Annual Meeting is in the best interest of each Fund and its shareholders in light of the similar matters being considered and voted on by the shareholders.
Expected output: 'entities: []'

Example #2: The Board of Directors The Corporate Trust Services division of Wells Fargo Bank, National Association: We have examined management s assessment, included in the accompanying Assessment of Compliance with Applicable Servicing Criteria, that The Corporate Trust Services division of Wells Fargo Bank, National Association (the Company) complied with the servicing criteria set forth in Item 1122 (d) of the Securities and Exchange Commission s Regulation AB for publicly-issued (i.e., transaction-level reporting initially required under the Securities Exchange Act of 1934, as amended) residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities, for which the Company provides master servicing, trustee, securities administration, or paying agent services, excluding transactions issued by any agency or instrumentality of the U.S. government or any government sponsored entity and further excluding the transactions issued prior to 2006 for which Wells Fargo outsources all material servicing activities (as defined by Regulation AB) (the Platform), except for servicing criteria 1122 (d) (4) (ii), 1122 (d) (4) (iv), 1122 (d) (4) (v), 1122 (d) (4) (viii), 1122 (d) (4) (ix), 1122 (d) (4) (x), 1122 (d) (4) (xi), 1122 (d) (4) (xii), and 1122 (d) (4) (xiii), which the Company has determined are not applicable to the activities it performs with respect to the Platform, as of and for the twelve months ended December 31, 2009.
Expected output: 'entities: [{'span': 'Wells Fargo Bank, National Association', 'entity': 'Business'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Regulation AB', 'entity': 'Legislation/Act'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'U.S.', 'entity': 'Location'}, {'span': 'Wells Fargo', 'entity': 'Business'}]'

Example #3: Investors may obtain a free copy of the proxy statement, as well as other filings containing information about Chemical Financial and OAK, free of charge from the SEC's website (www.sec.gov); by contacting Chemical Financial Corporation, 333 East Main Street, PO Box 569, Midland, MI 48640-0569, Attention: Ms. Lori A. Gwizdala, Investor Relations, telephone 800-867-9757 or by contacting O.A.K. Financial Corporation, 2445 84th Street, SW, Byron Center, MI 49315, Attention: Mr. James A. Luyk, Investor Relations, telephone 616-599-7419.
Expected output: 'entities: [{'span': 'Chemical Financial', 'entity': 'Business'}, {'span': 'OAK', 'entity': 'Business'}, {'span': 'SEC', 'entity': 'Government'}, {'span': 'Chemical Financial Corporation', 'entity': 'Business'}, {'span': 'East Main Street', 'entity': 'Location'}, {'span': 'Midland', 'entity': 'Location'}, {'span': 'MI', 'entity': 'Location'}, {'span': 'Lori A. Gwizdala', 'entity': 'Person'}, {'span': 'O.A.K. Financial Corporation', 'entity': 'Business'}, {'span': '84th Street, SW', 'entity': 'Location'}, {'span': 'Byron Center', 'entity': 'Location'}, {'span': 'James A. Luyk', 'entity': 'Person'}]'

Example #4: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #5: The undersigned hereby makes, constitutes and appoints each of Michael J. Berner and Douglas W. Ambrose as the undersigned ’ s true and lawful authorized representative, attorney-in-fact and agent, each with the power individually to execute for and on behalf of the undersigned and to file with and deliver to the United States Securities and Exchange Commission and any other authority or party required or entitled to receive the same: (a) any Forms 3, 4 and 5, and any amendments thereto, in accordance with Section 16 (a) of the Securities Exchange Act of 1934, as amended (the “ 1934 Act ”), and the rules promulgated thereunder; and (b) any Schedule 13D or Schedule 13G, and any amendments thereto, on behalf of the undersigned in accordance with Section 13 of the 1934 Act and the rules promulgated thereunder.
Expected output: 'entities: [{'span': 'Michael J. Berner', 'entity': 'Person'}, {'span': 'Douglas W. Ambrose', 'entity': 'Person'}, {'span': 'United States Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Forms 3, 4 and 5', 'entity': 'Miscellaneous'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': '1934 Act', 'entity': 'Legislation/Act'}, {'span': 'Schedule 13D', 'entity': 'Miscellaneous'}, {'span': 'Schedule 13G', 'entity': 'Miscellaneous'}]'

Example #6: Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Seattle, State of Washington, on April 1, 2011.
Expected output: 'entities: [{'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Form S-3', 'entity': 'Miscellaneous'}, {'span': 'City of Seattle', 'entity': 'Location'}, {'span': 'State of Washington', 'entity': 'Location'}]'

Example #7: These experience requirements may vary depending on the current composition of the Board, since the goal is to ensure an appropriate range of skills and experience, in the aggregate.
Expected output: 'entities: []'

Example #8: The number of regular quarterly meetings and special meetings held by the Board of each Fund during the Fund s last fiscal year is shown in Appendix C. During the last fiscal year, each Board Member attended 75 % or more of each Fund s Board meetings and the committee meetings (if a member thereof) held during the period for which such Board Member was a Board Member.
Expected output: 'entities: []'

Example #9: In connection with this Annual Report of Beauty Brands Group, Inc. (the “ Company ”) on Form 10-K for the year ending December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, James Altucher, Chairman of the Board of Directors and President of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Beauty Brands Group, Inc.', 'entity': 'Business'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': 'James Altucher', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #10: The inspectors of election will treat abstentions and broker non-votes (i.e., shares held by brokers or nominees, typically in street name, as to which (i) instructions have not been received from the beneficial owners or persons entitled to vote and (ii) the broker or nominee does not have discretionary voting power on a particular matter) as present for purposes of determining a quorum.
Expected output: 'entities: []'

Example #11: In connection with the Quarterly Report of Reach Messaging Holdings, Inc. (the “ Company ”) on Form 10-Q for the period ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, Shane Gau, Chief Executive Officer of the Company, certify to my knowledge and in my capacity as an officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Reach Messaging Holdings, Inc.', 'entity': 'Business'}, {'span': 'Form 10-Q', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Shane Gau', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #12: For purposes of determining the approval of the proposal to elect nominees for each Fund, abstentions and broker non-votes will have no effect on the election of Board Members.
Expected output: 'entities: []'

Example #13: The Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys ’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.
Expected output: 'entities: [{'span': 'Court of Chancery of the State of Delaware', 'entity': 'Court'}, {'span': 'Court of Chancery', 'entity': 'Court'}]'

Example #14: The nominating and governance committee looks to many sources for recommendations of qualified candidates, including current Board Members, employees of the Adviser, current shareholders of the Funds, third party sources and any other persons or entities that may be deemed necessary or desirable by the committee.
Expected output: 'entities: []'

Example #15: Based on the committee s review and discussions with management and the independent registered public accounting firm, the representations of management and the report of the independent registered public accounting firm to the committee, the committee has recommended that the audited financial statements be included in each Fund s Annual Report.
Expected output: 'entities: []'

Example #16: Recommendations for candidates to the Board will be evaluated in light of whether the number of Board members is expected to change and whether the Board expects any vacancies.
Expected output: 'entities: []'

Example #17: (b) a fee of $ 2,500 per meeting for attendance in person where such in-person attendance is required and $ 1,500 per meeting for attendance by telephone or in person where in-person attendance is not required at a special, non-regularly scheduled board meeting; (c) a fee of $ 2,000 per meeting for attendance in person or $ 1,500 per meeting for attendance by telephone at an audit committee meeting; (d) a fee of $ 2,000 per meeting for attendance at a regularly scheduled compliance, risk management and regulatory oversight committee meeting for regular quarterly meetings and $ 1,000 per meeting for attendance of other, non-quarterly meetings; (e) a fee of $ 1,000 per meeting for attendance in person or by telephone for a meeting of the dividend committee; and (f) a fee of $ 500 per meeting for attendance in person at all other committee meetings, $ 1,000 for attendance at shareholder meetings, on a day on which no regularly scheduled board meeting is held in which in-person attendance is required, $ 250 per meeting for attendance by telephone at all other committee meetings (excluding shareholder meetings) where in-person attendance is not required and $ 100 per meeting when the executive committee acts as pricing committee for IPOs, plus, in each case, expenses incurred in attending such meetings.
Expected output: 'entities: []'

Example #18: This Information Statement has been filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), to the holders (the “ Stockholders ”) of the common stock, par value $ .0001 per share (the “ Common Stock ”), of Comcam, Inc., a Delaware Corporation (the “ Company ”), to notify such Stockholders that on or about March 5, 2010, the Company received written consents in lieu of a meeting of Stockholders from holders of 683,952,500 shares representing approximately 91 % of the 744,640,134 shares of the total issued and outstanding shares of voting stock of the Company (the “ Majority Stockholders ”) to authorize 1-for-85 reverse stock split (pro-rata reduction of outstanding shares) of our issued and outstanding shares of Common Stock (the “ Reverse Stock Split ”).
Expected output: 'entities: [{'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Comcam, Inc.', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}]'

Example #19: The following table sets forth, for each Board Member nominee and for the Board Member nominees and officers as a group, the amount of shares beneficially owned in each Fund as of December 31, 2009.
Expected output: 'entities: []'

Example #20: The persons named in the enclosed proxy may also move for an adjournment of any Annual Meeting to permit further solicitation of proxies with respect to the proposal if they determine that adjournment and further solicitation is reasonable and in the best interests of the shareholders.
Expected output: 'entities: []'

